America Authorizes Johnson & Johnson’s COVID-19 Vaccine For Emergency Use

America’s Food and Drug Administration just authorized Johnson & Johnson’s COVID-19 vaccine for emergency use, according to CBS News. “The vaccine is the third to be approved for use in the United States, and the first that requires only one shot…”

Among people who got the vaccine in clinical trials, there were no COVID-related deaths. Phase 3 clinical trials also showed protection against multiple emerging virus variants, including a more contagious strain that was first discovered in South Africa and has since been detected in the U.S.

The vaccine can be stored at standard refrigerator temperatures for up to three months.

More from the BBC:
The company has agreed to provide the U.S. with 100 million doses by the end of June. The first doses could be available to the US public as early as next week. The U.K., EU and Canada have also ordered doses, and 500 million doses have also been ordered through the Covax scheme to supply poorer nations.

Read more of this story at Slashdot.

Source: Slashdot